Cancer Advances, AI Records, and Health Costs

Kilder

• STAT: STAT+: One of the most consequential years for cancer treatment, ever
• STAT: FDA approves Ultragenyx gene therapy - STAT
• STAT: STAT+: FDA approves Ultragenyx gene therapy
• STAT: STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more
• STAT: STAT+: How health systems are embracing chatbots to query and summarize patient records
• Thehill: Schwartz recognizes CDC strife in first talks with staff - The Hill
• Beckershospitalreview: Employer healthcare costs to top $19K per worker: 5 things to know
• Seeking Alpha: Employer healthcare costs to rise 9.5% in 2027 - Aon - Seeking Alpha
• STAT: STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection
• STAT: Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study
• STAT: Opinion: The global health aid architecture is collapsing. The faith economy isn’t
• STAT: Reduce protein to increase longevity? Nutrition experts say that’s a bad idea - STAT
• wikimedia: Photo by Steve Jurvetson from Los Altos, USA / Wikimedia Commons / CC BY 2.0

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.